ArticleProceedings of the National Academy of Sciences of the United States of America2015

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors.

Anneleen Daemen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.